Effectiveness and Safety of Tofacitinib for Ulcerative Colitis: Systematic Review and Meta-analysis
Conclusions:
While the overall efficacy and safety of tofacitinib in moderate-severe UC is consistent with clinical trial data, the dose dependent increase in AEs highlights the significance of early dose de-escalation. Rate of clinical response after tofacitinb induction was similar in biologic naive and biologic experienced patients.
Source: Journal of Clinical Gastroenterology - Category: Gastroenterology Tags: Online Article: Original Article Source Type: research
More News: Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Gastroenterology | Heart | Inflammatory Bowel Disease | Science | Squamous Cell Carcinoma | Study | Ulcerative Colitis